DeltaFosB: He Molecular Switch for Reward (2013)

Ka Palapala Noiʻi a me ka Waiʻona

vol. 2 (2013), NĀ ID 235651, Nāʻaoʻao 11

Pī'ānae PDF piha

hana: 10.4303 / jdar / 235651

E hoʻomaopopo '

1. MA Alibhai, TA Green, JA Potashkin, a me EJ Nestler, Ke hoʻoponopono o ka hua'ōlelo FosB a me fFB mRNA: i loko o nā mea ola a me nā mea in vitro, Kī Brain, 1143 (2007), 22-33.
2. E. Ang, J. Chen, P. Zagouras, H. Magna, J. Holland, E. Schaeffer, et al., ʻO ka hoʻokūkūʻana o ka huahana Biliana-B i loko o ka pūpū e hoʻokauʻia e ka hoʻomaluʻana i ka cocaine, J Neurochem, 79 (2001), 221-224.
3. Mr. Asanuma a me JL Cadet, Ke hoʻonuiʻia ka hānaiʻana o ka Methamphetamine ma ka NF-B e paʻa ana i ka hana DNA ma nā supcixide dismutase transiceic mice, Mol Brain Res, 60 (1998), 305-309.
4. O. Berton, HE Covington 3, K. Ebner, NM Tsankova, TL Carle, P. Ulery, et al., Ke kuhi o ka? FosB ma ke aniani periaqueductal ma muli o ka ikaika e hoʻonāukiuki i nā pane, Neuron, 55 (2007), 289-300.
5. JA Bibb, J. Chen, JR Taylor, P. Svenningsson, A. Nishi, GL Snyder, et al., Hoʻoponoponoʻia ka hopena o ka hōʻikeʻana i ka cocaine e ka neuronal protein Cdk5, Nature, 410 (2001), 376-380.
6. H. Bird, Kaʻike o nā epigenetics, Nature, 447 (2007), 396-398.
7. TL Carle, YN Ohnishi, YH Ohnishi, IN Alibhai, MB Wilkinson, A. A., a me al., Nā mana hana palekana a me ke kumuhana no ka FosB destabilization: kaʻikeʻana i nā inoa kikowaena o FosB a me nā hopena no ka kūpaʻa FosB, Eur J Neurosci, 25 (2007), 3009-3019.
8. J. Chen, MB Kelz, BT Hope, Y. Nakabeppu, a me EJ Nestler, ʻO nā antigens e pili ana i nā pili: nā mea likeʻole o?ʻO ka FosB i hoʻokomoʻia i loko o ka lolo e nā hōʻailona maʻamau, J Neurosci, 17 (1997), 4933-4941.
9. J. Chen, MB Kelz, G. Zeng, N. Sakai, C. Steffen, PE Peke, et al., Nā holoholona transgenic me ka hoʻonāukiʻole, i ka manaʻo o ka huaʻano i ka lolo, Mol Pharmacol, 54 (1998), 495-503.
10. J. Chen, SS Newton, L. Zeng, DH Adams, AL Dow, TM Madsen, et al., Downregulation o ka beta protein o ka CCAAT-enhancer e hoʻopaʻa ana i nā kinipona pilikino i loko o kaʻiole transgenic FosB a me ka hopuʻana i ka electroconvulsive, Neuropsychopharmacology, 29 (2004), 23-31.
11. J. Chen, HE Nye, MB Kelz, N. Hiroi, Y. Nakabeppu, BT Hope, et al., Ka hooponopono o? FosB a me nā proteins like pūnaewele FosB e ka hopena a me ka hana cocaine, Mol Pharmacol, 48 (1995), 880-889.
12. J. Chen, Y. Zhang, MB Kelz, C. Steffen, ES Ang, L. Zeng, et al., Ke kuʻiʻana o ka 5 kinui-kinui kalaponi i ka hippocampus e ka hopena electroconvulsive maʻamau: ke kuleana o? FosB, J Neurosci, 20 (2000), 8965-8971.
13. ʻO CR Colby, K. Whisler, C. Steffen, EJ Nestler, a me DW Pūʻali, ʻO kaʻike nui o keʻano o ka pūnaewele kūlohelohe?ʻO ka FosB e hoʻonui i ka mea hoʻoikaika i ka cocaine, J Neurosci, 23 (2003), 2488-2493.
14. D. Damez-Werno, Q. LaPlant, H. Sun, KN Scobie, DM Dietz, IM Walker, a me al., ʻO ka hopena o ka lāʻau i ka epigenetically preimes Fosb gene e hoʻoikaika i ka rat nucleus accumbens, J Neurosci, 32 (2012), 10267-10272.
15. P. Dobrazanski, T. Noguchi, K. Kovary, CA Rizzo, PS Lazo, ame R. Bravo, ʻO nā huahanaʻelua o ka gene fosB, FosB a me konaʻano liʻiliʻi, FosB / SF, he mau mea hoʻohui kahe ma ka fibroblasts, Mol Cell Biol, 11 (1991), 5470-5478.
16. ME'Ehrlich, J. Sommer, E. Canas, a me EM Unterwald, Hōʻikeʻia ka mice paʻiwaulu e hoʻonuiʻia?, J Neurosci, 22 (2002), 9155-9159.
17. D. Ferguson, N. Shao, J. Koo, J. Feng, V. Vialou, D. Dietz, et al., ʻO ke kūʻana o nā hanauna i ka hoʻohanaʻana i ChIP-Seq he mea nui ia no ka SIRT1 i loko o kaʻili liʻiliʻi, Neuroscience Meeting Planner, Polokalamu 778.09, Pūnaewele no Neuroscience, New Orleans, LA, 2012.
18. ʻO AM Graybiel, R. Moratalla, a me HA Robertson, ʻO Amphetamine a me ka cocaine e hana ai i ka hoʻouluʻana i ka lāʻau lapaʻau o ka c-fos i loko o nā puʻupuʻu-matrix a me nā māhele limbic o ka striatum, Hoʻokena Natl Acad Sci USA, 87 (1990), 6912-6916.
19. BA Grueter, AJ Robison, RL Neve, EJ Nestler, a me RC Malenka, ? FosB i ke 'ano likeʻole e hoʻololi i ka hana a pololei a me ke ala pololei, Hoʻokena Natl Acad Sci USA (e hele).
20. VL Hedges, S. Chakravarty, EJ Nestler, a me RL Meisel, ʻO ka hōʻike o ka hōʻike i loko o ka puʻupuʻu accumbens e hoʻonui i ka uku pili i ka wahine i ka wahine, Genes Brain Behav, 8 (2009), 442-449.
21. N. Hiroi, JR Brown, CN Haile, H. Ye, ME Greenberg, a me EJ Nestler, Nāʻiole mutent FosB: ka lilo o ka hoʻokomo cocaine mau o nā protein pili i Fos a hoʻonui i ka ʻike i ka psychomotor a cocaine a me nā hopena maikaʻi., Hoʻokena Natl Acad Sci USA, 94 (1997), 10397-10402.
22. N. Hiroi, GJ Marek, JR Brown, H. You, F. Saudou, VA Vaidya, et al., Ka hana nui o ka genes fosba i ka molekika, ke kelepona, a me nā hana o ka hanaʻana i nā ponole electroconvulsive, J Neurosci, 18 (1998), 6952-6962.
23. B. Hope, B. Kosofsky, SE Hyman, a me EJ Nestler, Hoʻoponopono i ka hoʻopuka muaʻana o ka hua'ōlelo mua a me ka AP-1 i hoʻopaʻaʻia i loko o ka pahu ratō e ulu ana i ka cocaine mau, Hoʻokena Natl Acad Sci USA, 89 (1992), 5764-5768.
24. BT Hope, HE KA, MB Kelz, DWʻOihana, MJ Iadarola, Y. Nakabeppu, et al., Ke kūʻana o kahi moʻomeheu AP-1 lōʻihi i hanaʻia me nā proteins likeʻole Fos i loko o ka lolo e ka cocaine maʻamau a me nā hōʻailona maʻamau, Neuron, 13 (1994), 1235-1244.
25. HJ Jorissen, PG Ulery, L. Henry, S. Gourneni, EJ Nestler a me G. Rudenko, Nā hana paʻa a me nā DNA o nā mea kākau o ka mea kākau? FosB, Biochemistry, 46 (2007), 8360-8372.
26. ʻO PW Kalivas a me ND Volkow, ʻO ke kumu kūlohelohe o ke kīpī: kahi pilikino o ka hoʻoikaika a me ke kohoʻana,'Am Lakikina, 162 (2005), 1403-1413.
27. GB Kaplan, KA LEite-Morris, W. Fan, AJ Young, a me MD Guy, I kaʻikeʻana o ka pīpī i ke kākoʻoʻana i ka FosB /? FosB manaʻo ma kaʻaoʻao mua o kaʻeha o ka lolo, kūlana a me amygdala, PLoS One, 6 (2011), e23574.
28. ʻO JA Kauer lāuaʻo RC Malenka, ʻO Synaptic ka paʻakikī a me ke kīpilikia, Nat Rev Neurosci, 8 (2007), 844-858.
29. MB Kelz, J. Chen, Carlezon Jr., WA, Jr., K. Whisler, L. Gilden, AM Beckmann, et al., Ke ho'ākākaʻana i ka mea kākau?ʻO ka FosB i loko o ka lolo e mālama i ka hiʻona i ka cocaine, Nature, 401 (1999), 272-276.
30. H.. Kumar, KH Choi, W. Renthal, NM Tsankova, DE Theobald, HT Truong, et al., ʻO ka hōʻaihoʻiʻana o Chromatin he mea hana nui ia e hoʻohuiʻia i ka cocaine i loko o striatum, Neuron, 48 (2005), 303-314.
31. N.- LaPlant a me EJ Nestler, E haki i ka code histone: nā hopena a ka cocaine ma ka hanana chromatin a me ka hana, Horm Behav, 59 (2011), 321-330.
32. KW Lee, Y. Kim, AM Kim, K. Helmin, AC Nairn, a me P. Greengard, Hoʻokumuʻia ka hana'enela dendritic i ka Cocaine i loko o D1 a me D2 dopamine i loko o ka'ōwili kikowaena i loko o ka pūpū accumbens, Hoʻokena Natl Acad Sci USA, 103 (2006), 3399-3404.
33. ML Lehmann a me Mr. Herkenham, Mālama ka hoʻopiliʻana i ka hoʻoikaika i ka hopena o ka pilikia i ka popilikia pōpilikia ma o kahi alana neuroanatomia e pili ana i ka cortex-cortex, J Neurosci, 31 (2011), 6159-6173.
34. H. Levine, Y. Huang, B. Drisaldi, EA Griffin Jr., DD Pollak, S. Xu, et al., ʻO ka hana i ka molecular no kahi gateway drug: nā hua'ōlelo epigenetic i hoʻomakaʻia e ka nicotine hua mua e ka cocaine, Sci Transl Med, 3 (2011), 107RA109.
35. ʻO AA Levine, Z. Guan, A. Barco, S. Xu, ER Kandel, a me JH Schwartz, ʻO ka hana CREB-paʻa hoʻomalu i ka pane i ka cocaine ma nā hana hoʻopiʻi hoʻoholo i ka mea hoʻolaha fosB i ka mīkini strictum, Hoʻokena Natl Acad Sci USA, 102 (2005), 19186-19191.
36. J. Li, Y. Sun, a me J. E, Hoʻoemi ke kohoʻana i ka hoʻohanaʻana i ka waiʻona no ka hoʻonuiʻana o nāʻaoʻao FosB /? FosB i kahi o ka lolo e pili ana i ka uku, PLoS One, 7 (2012), e40347.
37. HF Liu, WH Zhou, HQ Zhu, MJ Lai, a me WS Chen, Ke kuʻiʻana o M₅ ka muscarinic receptor antisense oligonucleotide i VTA inhibits ka FosB hōʻike ma ka NAc a me ka hippocampus o heroin iʻike i nāʻiole, Neurosci Bull, 23 (2007), 1-8.
38. I. Maze, HE Covington 3rd, DM Dietz, Q. LaPlant, W. W. Hoime, SJ Russo, et al., ʻO ka pono nui o ka histone methyltransferase G9a i loko o ka ulana kokopiko, Science, 327 (2010), 213-216.
39. CA McClung a me EJ Nestler, Ka hoʻolālāʻana i ka hōʻailona hua'ōlelo a me ka ukuʻai koko hou e ka CREB a me ka FosB, Nat Neurosci, 6 (2003), 1208-1215.
40. CA McClung, PG Ulery, LI Perrotti, V. Zachariou, O. Berton, a me EJ Nestler, ? FosB: he kinikiki mole no ka manawa loihi i ka lolo, Mol Brain Res, 132 (2004), 146-154.
41. J. McDaid, JE Dallimore, AR Mackie, a me TC Napier, Nā hoʻololi i loko o ka pahu me ka pCREB pallidal a me ka FosB ma nāʻiole i loaʻa i ka morphine: nā hoʻoponoponoʻana me nā mea electrophysiological i hoʻopiliʻia ma ka'āpana i ka pallidum ākea, Neuropsychopharmacology, 31 (2006), 1212-1226.
42. J. McDaid, MP Graham, a me TC Napier, Hoʻohālikelike i hoʻokomoʻia ka Methamphetamine i nāʻano likeʻole pCREB a me? FosB ma ka holoʻokoʻa limbic o ka lolo lolo, Mol Pharmacol, 70 (2006), 2064-2074.
43. C. Halawai, L. Lhuillier, K. Kaupmann a me JF Cryan, ʻO ka GABAB receptor-kūpono i ka hoʻopiliʻana i nā mea waiwai o ka nicotine e pili ana i ka ho'ēmiʻana o ka pilikino nui?, J Pharmacol Exp Ther, 321 (2007), 172-177.
44. R. Moratalla, B. Elibol, M. Vallejo, ame AM Graybiel, Nā hoʻololi o ka pūnaewele ma ka hōʻailona o nā protein Fos-Jun i hoʻokomoʻoleʻia i ka striatum i ka manawa o ka mālamaʻana i ka cocaine maʻamau a me ka weheʻana., Neuron, 17 (1996), 147-156.
45. ʻO JI Morgan a me T. Curran, Nā kinai mua koke: heʻumi makahiki ma, Nā Trends Neurosci, 18 (1995), 66-67.
46. DL Muller a me EM Unterwald, Hiki i nā DTSNUMX dopamine ka hoʻoponoponoʻana?, J Pharmacol Exp Ther, 314 (2005), 148-154.
47. J. Muschamp, C. Nemeth, A. Robison, E. Nestler, ame W. Carlezon Jr., ? Hoʻonui ka FosB i nā hopena hoʻomaikaʻi o ka cocaine ma ka ho'ēmiʻana i nā hopena hoʻopilikia o ka'āpana o ka'āpana Kappa-opioid U50488., Biol Psychiatry, 71 (2012), 44-50.
48. ʻO Y. Nakabeppu lāuaʻo D. Nathans, ʻO keʻano o ka FosB i hanaʻia e kahe ana i ka hana Fos / Jun, Pūnaewele, 64 (1991), 751-759.
49. EJ Nestler, ʻO ke kumu kūponoʻole o ka makeʻana o kaʻili, Nat Rev Neurosci, 2 (2001), 119-128.
50. EJ Nestler, Nā hana i kākauʻia o ka pīpī: ka hana o? FosB, Philos Trans R Soc Lond B Biol Sci, 363 (2008), 3245-3255.
51. EJ Nestler, MB Kelz, a me J. Chen, ? FosB: he mea mea hana pilikino o ka neu a me ke ano o ka ulaula, Kī Brain, 835 (1999), 10-17.
52. SD Norrholm, JA Bibb, EJ Nestler, CC Ouimet, JR Taylor, a me P. Greengard, ʻO ka hoʻonuiʻana i ka cocaine o nā'āpana dendritic i loko o ka hale accumbens e pili ana i ka hana o ka kinase-kinolino pili-5, Neuroscience, 116 (2003), 19-22.
53. ʻO HE Nye, B. Hope, M. Kelz, M. Iadarola, a me E. Nestler, Nāʻike hoʻomau no ka hoʻomaʻamaʻa pharmacological no ka hoʻoponoponoʻana i ka hoʻokomoʻiaʻana o nā antigen inikopiko pūnaewele e ka FOS e ka cocaine i loko o ka striatum a me ka hoʻokipa nui., J Pharmacol Exp Ther, 275 (1995), 1671-1680.
54. ʻO HE Nye a me EJ Nestler, Ka hopena o nā antigens e pili ana i ka Fos ma ka lolo e ka hānaiʻana i ka hānai, Mol Pharmacol, 49 (1996), 636-645.
55. P. Olausson, JD Jentsch, N. Tronson, RL Neve, EJ Nestler, a me JR Taylor, ? Hoʻoponopono ka FosB i loko o ka puʻupuʻu nui i ka hana a me ka hoʻoikaika i ka meaʻai, J Neurosci, 26 (2006), 9196-9204.
56. MC Peakman, C. Colby, LI Perrotti, P. Tekumalla, T. Carle, P. Ulery, et al., ʻO kaʻikeʻole, kaʻike o ka lolo ma ka'āpana'āina o ka meaʻona maikaʻiʻole o C-Jun ma nāʻiole transgenic e emi iho ai kaʻike i ka cocaine, Kī Brain, 970 (2003), 73-86.
57. LI Perrotti, CA Bolan ~ os, KH Choi, SJ Russo, S. Edwards, PG Ulery, et al., Hiki i ka FosB ke hōʻiliʻili i loko o ka heluna kanaka maʻamau i GABAeric ma ka piko hope o ka mahele kaʻina o ka ventral ma hope o ka lawelaweʻana o psychostimulant., Eur J Neurosci, 21 (2005), 2817-2824.
58. ʻO LI Perrotti, Y. Hadeishi, PG Ulery, M. Barrot, L. Monteggia, RS Duman, et al., Ke kuhiʻia o? FosB i loko o nā hanana i pili i ka uku ma muli o ke kaumaha nui, J Neurosci, 24 (2004), 10594-10602.
59. LI Perrotti, RR Weaver, B. Robison, W. Renthal, I. Maze, S. Yazdani, et al., Nā kinona maʻamau o ka FosB i hoʻokomoʻia i ka lolo e ka lāʻau hoʻomāinoino, Synapse, 62 (2008), 358-369.
60. EM Pich, SR Pagliusi, M. Tessari, D. Talabot-Ayer, R. Hooft van Huijsduijnen a me C. Chiamulera, Nā kuʻomena neural maʻamau no nā meaʻaʻai o ka nicotine a me ka cocaine, Science, 275 (1997), 83-86.
61. KK Pitchers, KS Frohmader, V. Vialou, E. Mouzon, EJ Nestler, MN Lehman, a me al., ? He mea koʻikoʻi ka FosB i loko o ka puʻupuʻu nui no ka hoʻoikaika i nā hopena o ka uku pilina, Genes Brain Behav, 9 (2010), 831-840.
62. W. W. Vinhal, TL Carle, I. Maze, HE Covington 3rd, HT Truong, I. Alibhai, et al., ? Paʻi ka FosB i ka hoʻopau 'ana i ka epigenetic o ka c-fos ma hope o ka wehe' ana i ka amphetamine, J Neurosci, 28 (2008), 7344-7349.
63. W. W. Vinhal, A. Kumar, G. Xiao, Mr. Wilkinson, HE Covington 3rd, I. Maze, et al., ʻO ka hoʻonuiʻana o ka chromatin regula e ka cocaine e hōʻike ana i kahi hana no nā sirtuins, Neuron, 62 (2009), 335-348.
64. W. W. Vinhal, I. Maze, V. Krishnan, HE Covington 3, G. Xiao, A. A., a me al., Histone deacetylase 5 epigenetically e hoʻoponopono i nā halihali halihali i nā hopena o ka naʻau, Neuron, 56 (2007), 517-529.
65. ʻO Rob Robinson lāuaʻo B. Kolb, ʻO ka'ilikalaʻoihana e pili ana i ka hopena i nā lāʻau lapaʻau, Neuropharmacology, 47 (2004), 33-46.
66. ʻO'AJ Robison lāuaʻo EJ Nestler, ʻO ka transcriptional a me ka epigenetic mechanisms o ka mea hōʻailona, Nat Rev Neurosci, 12 (2011), 623-637.
67. AJ Robison, V. Vialou, Mr. Mazei-Robison, J. Feng, S. Kourrich, Mr. Collins, et al., Pono nā kūhālike a me nā pane i ka cocaine maʻamau e pono ai i kahi loop loop in front? FosB a me CaMKII i loko o ka shell accumbens, J Neurosci (e hele).
68. SJ Russo, MB Wilkinson, MS Mazei-Robison, DM Dietz, I. Maze, V. Krishnan, et al., ʻO ka mea hana nucleiʻo B ka mea e hoʻoponopono ai i ka morphology neuronal a me ka ukuʻai hou, J Neurosci, 29 (2009), 3529-3537.
69. HJ Shaffer a me GB Eber, ʻO ka piʻiʻana o ka cocaine i ke kino o ka hilinaʻi i nā hōʻailona ma ka US National Comorbidity Survey, Hoʻoponopono, 97 (2002), 543-554.
70. ʻO T. Shippenberg lāuaʻo W. Rea, Ka hoʻomanaʻoʻana i ka hopena o ka hana cocaine: ka hoʻololiʻana o ka'āpana dynorphin a me kappa-opioid agonists, Pharmacol Biochem Behav, 57 (1997), 449-455.
71. J. Taylor, W. Lynch, H. Sanchez, P. Olausson, E. Nestler, a me J. Bibb, ʻO ka pāpāʻana o Cdk5 i loko o ka pilikino accumbens e hoʻonui i ka hopena o ka loca-activation a me nā mea hoʻonāukiuki o ka cocaine., Hoʻokena Natl Acad Sci USA, 104 (2007), 4147-4152.
72. SL Teegarden a me TL Bale, ʻO ka emiʻana i ka makemake meaʻai hoʻonui i ka manaʻo a me ke kūpono no ka hoʻihoʻi houʻana, Biol Psychiatry, 61 (2007), 1021-1029.
73. SL Teegarden, EJ Nestler, a me TL Bale, ʻO ka hoʻololiʻana i ka hoʻopiliʻana o ka dopamine i ka mea i hanaʻia e ka palaʻai ka momona, Biol Psychiatry, 64 (2008), 941-950.
74. PG Ulery, G. Rudenko, a me EJ Nestler, ʻO ke kauʻana o ka pale FosB e ka phosphorylation, J Neurosci, 26 (2006), 5131-5142.
75. ʻO PG Ulery-Reynolds, MA Castillo, V. Vialou, SJ Russo, a me EJ Nestler, ʻO ka Phosphorylation o? FosB e hoʻokūpaʻa i kona paʻa i vivo, Neuroscience, 158 (2009), 369-372.
76. V. Vialou, J. Feng, AJ Robison, SM Ku, D. Ferguson, KN Scobie, et al., ʻO ka mea pane maʻamau a me ka pane'eleka CAMP e paʻa ana i ke kinipona e ponoʻia no ka hanaʻana i ka cocaine o? FosB, J Neurosci, 32 (2012), 7577-7584.
77. V. Vialou, I. Maze, W. Wallhal, QC LaPlant, EL Watts, E. Mouzon, et al., ʻO ka pane pāʻani maʻamau ka hoʻonāukiuki i ka pilikia ma ka hanaʻana i ka FosB, J Neurosci, 30 (2010), 14585-14592.
78. V. Kahikina, HI Kaneohe, HI Laplant, HE Covington 3rd, DM Dietz, YN Ohnishi, et al., ʻO ka FosB i loko o ka pōʻaleʻa pili kālā e hoʻopili i ka hopena i nā pane a me nā antidepressant, Nat Neurosci, 13 (2010), 745-752.
79. DL Wallace, V. Vialou, L. Rios, TL Carle-Florence, S. Chakravarty, A. A., a me al., ʻO ka hopena o ka FosB i loko o ka pūnaewele e hoʻokūpaʻa i ka halihali pili i ka maikaʻi, J Neurosci, 28 (2008), 10272-10277.
80. Y. Wang, TI Cesena, Y. Ohnishi, R. Burger-Caplan, V. Lam, PD Kirchhoff, et al., ʻO ka nānāʻana o ka mole liʻiliʻi eʻike i nā mea hoʻoholo i ka mea kākau? FosB, ACS Chem Neurosci, 3 (2012), 546-556.
81. Mr. Werme, C. Messer, L. Olson, L. Gilden, P. Thorén, EJ Nestler, et al., ? Na ka FosB e hoʻoholo i nā huila e holo ana, J Neurosci, 22 (2002), 8133-8138.
82. CA Winstanley, RK Bachtell, DE Theobald, S. Laali, TA Green, A. Kumar, et al., Hoʻonuiʻia ka impulsivity i ka wā e haʻalele ai i ka hana hoʻomaluʻiaʻana o ka cocaine: ka hana no? FosB i loko o ka cortex orbitofrontal, Cereb Cortex, 19 (2009), 435-444.
83. CA Winstanley, TA Green, DE Theobald, W. Renthal, Q. LaPlant, RJ DiLeone, et al., ʻO ka hoʻokomoʻia ka FosB i loko o ka hopena o ka maʻi kino e hiki ai ke hoʻonuiʻia ka locomotor ma muli o ke kaohiʻana i ka maʻi'eleʻaleʻa i hanaʻia e ka cocaine., Pharmacol Biochem Behav, 93 (2009), 278-284.
84. CA Winstanley, Q. LaPlant, DE Theobald, TA Green, RK Bachtell, LI Perrotti, et al., ʻO ka hoʻokomoʻana o ka FTB i loko o ka cortex ma ka papahana hoʻopunipuni i ka hoʻomanawanuiʻana i nā hanaʻeleu o ka cocaine-induced, J Neurosci, 27 (2007), 10497-10507.
85. J. Yen, RM Wisdom, I. Tratner, a me IM Verma, ʻO kekahiʻano'ē aʻe o FosB he mea hoʻokele ponoʻole o ka hoʻonāʻana o ka transcriptional a me ka hoʻololiʻana e nā pūnaewele Fos, Hoʻokena Natl Acad Sci USA, 88 (1991), 5077-5081.
86. ʻO ST Young, LJ Porrino, a me MJ Iadarola, Hoʻokumuʻia ka cocaine i nā kāpena c-fos-immunoreactive ma o nā transptors D1 dopaminergic, Hoʻokena Natl Acad Sci USA, 88 (1991), 1291-1295.
87. V. Zachariou, CA Bolanos, DE Selley, D. Theobald, MP Cassidy, MB Kelz, et al., He kuleana nui no? FosB i loko o ka puʻukū e hoʻokū i ka hana morphine, Nat Neurosci, 9 (2006), 205-211.